Table 2 Results from pilot integrated testing activities
Organisation | Tested infection | No. of individuals tested | No. of individuals with reactive screening (No. of known positive status) | Newly diagnosed infections per 100 tests | No. previously tested within the past 12 months |
|---|---|---|---|---|---|
HUHIV | HIV | 341 | 2 (−) | 0.6% | 72 (21%) |
HCV | 197 | 2 (−) | 1.0% | 36 (18%) | |
Syphilis | 144 | 3 (−) | 2.1% | - | |
Chlamydia | 89 | 11 (−) | 12.4% | 13 (15%) | |
Gonorrhoea | 89 | 6 (−) | 6.7% | 13 (15%) | |
FVM/CRI | HIV | 64 | 0 (−) | 0.0% | 15 (24%) |
HCV | 64 | 0 (−) | 0.0% | 7 (11%) | |
FVM | HIV | 250 | 0 (−) | 0.0% | 82 (33%) |
HCV | 242 | 15 (−) | 6.2% | 75 (31%) | |
FES | HIV | 95 | 0 (6) | 0.0% | 39 (39%) |
HCV | 76 | 5 (20) | 6.6% | 36 (37%) | |
HBV | – | – | – | 4 (4%) | |
Syphilis | 100 | 0 (1) | 0.0% | 38 (38%) |